Northwest Biotherapeutics (NWBO) Goodwill (2020 - 2026)
Northwest Biotherapeutics (NWBO) posted quarterly Goodwill of $626000.0 for Q1 2026, little changed year-over-year from $626000.0 in Q1 2025, and little changed quarter-over-quarter from $626000.0 in Q4 2025.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Goodwill (2020 - 2026) Analysis & Trends
Northwest Biotherapeutics' Goodwill history runs 7 years deep, the most recent figure standing at $626000.0 for Q1 2026.
- In Q1 2026, Goodwill changed 0.0% year-over-year to $626000.0; the TTM figure through Mar 2026 stood at $626000.0 (changed 0.0% YoY), while the FY2025 annual figure was $626000.0, changed 0.0% from the prior year.
- Goodwill for Q1 2026 stood at $626000.0, roughly flat from $626000.0 in the prior quarter.
- The five-year high for Goodwill was $626000.0 in Q1 2022, with the low at $626000.0 in Q1 2022.
- The 5-year median for Goodwill is $626000.0 (2022), against an average of $626000.0.
- Peak annual rise in Goodwill reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
- Northwest Biotherapeutics' Goodwill stood at $626000.0 in 2022, then changed by 0.0% to $626000.0 in 2023, then changed by 0.0% to $626000.0 in 2024, then changed by 0.0% to $626000.0 in 2025, then changed by 0.0% to $626000.0 in 2026.
- Business Quant data shows NWBO's Goodwill at $626000.0 in Q1 2026, $626000.0 in Q4 2025, and $626000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Northwest Biotherapeutics | 278.23 Mn | 277.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 626,000.00 |
| Mar 31, 2026 | 626,000.00 |
| Dec 31, 2025 | 626,000.00 |
| Sep 30, 2025 | 626,000.00 |
| Jun 30, 2025 | 626,000.00 |
| Mar 31, 2025 | 626,000.00 |
| Dec 31, 2024 | 626,000.00 |
| Sep 30, 2024 | 626,000.00 |
| Jun 30, 2024 | 626,000.00 |
| Mar 31, 2024 | 626,000.00 |
| Dec 31, 2023 | 626,000.00 |
| Sep 30, 2023 | 626,000.00 |
| Jun 30, 2023 | 626,000.00 |
| Mar 31, 2023 | 626,000.00 |
| Dec 31, 2022 | 626,000.00 |
| Sep 30, 2022 | 626,000.00 |
| Jun 30, 2022 | 626,000.00 |
| Mar 31, 2022 | 626,000.00 |
| Dec 31, 2021 | 626,000.00 |
| Sep 30, 2021 | 626,000.00 |